CoChat

An investigation of microRNA‐103 and microRNA‐107 as potential blood‐based biomarkers for disease risk and progression of Alzheimer's disease

Open access
Wang, Jie, Chen, Chunyan, Zhang, Yun · 2020 · Journal of Clinical Laboratory Analysis
Cited by 62

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Background: This study aimed to assess the correlation of circulating microRNA‐103 (miR‐103) and microRNA‐107 (miR‐107) with disease risk and cognitive impairment of Alzheimer's disease (AD). Methods: Plasma samples from 120 AD patients, 120 Parkinson's disease (PD) patients (served as disease control), and 120 healthy controls were collected for miR‐103 and miR‐107 detections using real‐time quantitative polymerase chain reaction. Mini‐Mental State Examination (MMSE) score was documented and was used to accordingly assess the dementia severity. Results: miR‐103 expression was decreased in AD patients compared with PD patients and healthy controls, and receiver operating characteristic (ROC) curve analyses illustrated that it was able to differentiate AD patients from PD patients and healthy controls. Additionally, miR‐103 positively correlated with MMSE score and negatively correlated with dementia severity in AD patients. miR‐107 expression was lower in AD patients compared with healthy controls but similar between AD patients and PD patients, and ROC curve analyses revealed that it was able to differentiate AD patients from healthy controls but not AD patients from PD patients. miR‐107 was positively correlated with MMSE score and negatively correlated with dementia severity in AD patients, while the correlation coefficient of miR‐107 with MMSE score was lower than that of miR‐103 with MMSE score. Besides, miR‐103 was positively correlated with miR‐107 in AD patients, PD patients, and healthy controls. Conclusion: miR‐103 may be a better choice than miR‐107 to serve as a potential biomarker for disease risk and disease progression of AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jcla.23006

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 62

Metadata

Authors
Wang, J., Chen, C., & Zhang, Y.
Venue
Journal of Clinical Laboratory Analysis
Publisher
Wiley
Published
2019-08-16
Volume
34
Issue
1
Pages
e23006-e23006
ISSN
  • 0887-8013 (ISSN-L)
  • 1098-2825
OpenAlex
W2967421572
Cited by
62
References
4
FWCI
1.59
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An investigation of microRNA‐103 and microRNA‐107 as potential blood‐based biomarkers for disease risk and progression of Alzheimer's disease. https://app.cochat.ai/papers/10.1002/jcla.23006
The paper
Wang, J., Chen, C., & Zhang, Y. (2020). An investigation of microRNA‐103 and microRNA‐107 as potential blood‐based biomarkers for disease risk and progression of Alzheimer's disease. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.23006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.